Literature DB >> 21412840

Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease.

Dario Benincasa, Clelia Pellicano, Alessandra Fanciulli, Francesco E Pontieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21412840     DOI： 10.1002/mds.23395

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  4 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 2.  [Repetitive impulse-associated behavioral disorders in Parkinson's disease].

Authors:  R Katzenschlager; K S Goerlich; T van Eimeren
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

Review 3.  Clinical uses of Bupropion in patients with Parkinson's disease and comorbid depressive or neuropsychiatric symptoms: a scoping review.

Authors:  Matteo Vismara; Beatrice Benatti; Gregorio Nicolini; Ilaria Cova; Edoardo Monfrini; Alessio Di Fonzo; Vincenza Fetoni; Caterina A Viganò; Alberto Priori; Bernardo Dell'Osso
Journal:  BMC Neurol       Date:  2022-05-05       Impact factor: 2.903

4.  Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism.

Authors:  Emma A Honkanen; Nina Kemppainen; Tommi Noponen; Marko Seppänen; Juho Joutsa; Valtteri Kaasinen
Journal:  Clin Neuropharmacol       Date:  2019 Sep/Oct       Impact factor: 1.592
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.